Phase IIb, Double-Blind, Randomized, Multicenter, Parallel Group, Placebo-Controlled, Dose-Finding Study to Evaluate the Efficacy, Safety and Tolerability of a 12-Week Treatment With ASP1941 in Combination With Metformin in Subjects With Type 2 Diabetes M.

Authors
Category Primary study
Year 2017
This article has no abstract
Epistemonikos ID: fe66c33e32b55b04e42bec403975b7eacc6ff51e
First added on: Nov 09, 2018